Hoth Therapeutics : and Virginia Commonwealth University Expand Research Agreement for COVID-19 Therapeutic
NEW YORK, May 5, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. , a biopharmaceutical company, today announced it has expanded its sponsored research agreement with Virginia... | May 5, 2021
Michael Peters Miriam Brito Exchange Commission Virginia Commonwealth University Lr Advisors Hoth Therapeutics Inc
Source: marketscreener.com